RT @neil_carleton_: Check out our new paper, out now in @MCR_AACR, with @eprasu leading the way! MALT1 is a Targetable Driver of Epitheli…
RT @neil_carleton_: Check out our new paper, out now in @MCR_AACR, with @eprasu leading the way! MALT1 is a Targetable Driver of Epitheli…
Check out our new paper, out now in @MCR_AACR, with @eprasu leading the way! MALT1 is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-low, Triple-Negative Breast Cancer https://t.co/cf6u6yu6Cb cc: @DrLMMcAllister https://t.co/Gbh
RT @DrLMMcAllister: So proud of our fantastic lab team! Congratulations @eprasu ! And huge thanks to all our wonderful collaborators @oest…
So proud of our fantastic lab team! Congratulations @eprasu ! And huge thanks to all our wonderful collaborators @oesterreichs @Adrianvlee
MALT1 is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-low, Triple-Negative Breast Cancer https://t.co/erGRycFnPA
RT @PaperbirdsO: New article: MALT1 is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-low, Triple-Negative Breast C…
New article: MALT1 is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-low, Triple-Negative Breast Cancer https://t.co/nfUGsmEq5I #breastcancer #oncology https://t.co/3FZGmtRiZT